Hubei Longxiang Pharmaceutical Tech,Co.,Ltd. was founded in February 2002 with registered capital of 115 million Yuan RMB. It&＃39;s controlling shareholder is Tianjin Ringpu Biotech Co., Ltd. (listed company, code 300119). Longxiang has listed on New Three Board in March 2017(Code:871082. Situated in Economic Development Zone of Wuxue City, Longxiang is a veterinary drugenterprise in accordance with GMP standard, and it owns self-managerial import and export rights. It is Torch Program undertaking enterprise, key high-tech enterprise of China,technological innovation demonstration enterprise. Our products toltrazuril and oxolinic acid won second prize for scientific and technological progress of Hubei in 2008. Florfenicol was rated as famous product of Hubei province in 2009 and 2012. In 2013, valnemulin hydrochloride premix was rated as famous product of Hubei province. In 2012, "Longxiang Pharmaceutical" trademark was evaluated as famous trademark of Hubei province. The company has won titles such as "top-10 veterinary material manufacturers" of China, top-100 enterprises of Huanggang city, top-10 enterprises in Wuxue city, "enterprise with harmonious labor relation", "observing contract and valuing credit enterprise", "labor security and best integrity unit", "home of model staff", "top-10 foreign trade enterprises", "financial integrity enterprise", "advanced unit for technology work", "advanced unit for safety production", "advanced unit for environmental protection", etc.Enterprise scale: registered capital is115 million Yuan. 300 employees. Annual production capacity: 300 tons of florfenicol, 200 tons of tilmicosin, 100 tons of oxolinic acid, 30 tons of toltrazuril, 5 tons of valnemulin, 800 tons of powdery, primix, coated agent and pellet.The company is regarded as "engineering and technological research center of APIs for synthesis of veterinary drug" and "enterprise technology center". It has established laboratory with Huazhong University of Science and Technology. The company has won second prize for scientific and technology profess of Hubei province, third prize for promoting scientific and technological achievements in Hubei province, technological innovation prize of Hubei province; second prize for scientific and technological prize of Huanggang city. At present, five technologies have won national invention patents. Valnemulin APIs and premix have won national class II veterinary drug certificate. Our products have been registered and sold in more than 20 provinces in China, as well as in Germany, Belgium, Japan, Iran, Mexico, Korea and other regions. Insisting on the core philosophy of "foresight, innovation, honesty, sharing", development philosophy of "integrity top, promoting industry by technology, progress by innovation, operation philosophy of "customer top, first-class product, pursuit of excellence, sell well across the world", the company strives to promote harmonious development between animal and human health, and harmony of human, nature, and society. We&＃39;ll become a supplier of high-quality APIs and featured preparations.